Converge Bio Inc.

Biotechnology company · Claymont, Delaware, United States

Converge Bio Inc. is a biotechnology company headquartered in Claymont, Delaware, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Converge Bio at a glance

Typebiotechnology company

HeadquartersClaymont, Delaware, United States

Earliest incorporation on record2024

SEC CIK2131104

What does Converge Bio do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $25 million sold (2026).

Frequently asked questions about Converge Bio

Where is Converge Bio headquartered?

Converge Bio Inc. is headquartered in Claymont, Delaware, United States.

What does Converge Bio do?

Converge Bio Inc. is a biotechnology company.

When was Converge Bio founded?

The earliest incorporation on record for Converge Bio Inc. is in 2024, according to public company registers.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences